Summary

The global market for Human Leukocyte Antigen (HLA) Typing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Human leukocyte antigen (HLA) typing determines if patients and donors are compatible for cord blood or bone marrow transplants. Human leukocyte antigens (HLA) are proteins found in our bodies. The human immune system uses these markers to determine which cells belong in your body and which cells are foreign.

North American market for Human Leukocyte Antigen (HLA) Typing was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Leukocyte Antigen (HLA) Typing was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Human Leukocyte Antigen (HLA) Typing was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Human Leukocyte Antigen (HLA) Typing include Thermo Fisher Scientific, QIAGEN, Illumina, CareDx, Immucor, Bio-Rad Laboratories, Inc, F. Hoffman-La Roche Ltd, Hologic, Inc, Luminex Corporation, Biofortuna, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Human Leukocyte Antigen (HLA) Typing, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Leukocyte Antigen (HLA) Typing by region & country, by Type, and by Application.
The Human Leukocyte Antigen (HLA) Typing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Leukocyte Antigen (HLA) Typing.

Market Segmentation
By Company
Thermo Fisher Scientific
QIAGEN
Illumina
CareDx
Immucor
Bio-Rad Laboratories, Inc
F. Hoffman-La Roche Ltd
Hologic, Inc
Luminex Corporation
Biofortuna
Bruker
Abbott
Takara Bio Inc
Omixon Inc
Siemens
EKF Diagnostics
BD
Fujirebio
TBG Diagnostics Limited
Segment by Type
Reagent
Instrument
Segment by Application
Hospital
Specialty Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Leukocyte Antigen (HLA) Typing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Leukocyte Antigen (HLA) Typing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Leukocyte Antigen (HLA) Typing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Human Leukocyte Antigen (HLA) Typing Product Introduction
1.2 Global Human Leukocyte Antigen (HLA) Typing Market Size Forecast
1.2.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value (2020-2031)
1.2.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume (2020-2031)
1.2.3 Global Human Leukocyte Antigen (HLA) Typing Sales Price (2020-2031)
1.3 Human Leukocyte Antigen (HLA) Typing Market Trends & Drivers
1.3.1 Human Leukocyte Antigen (HLA) Typing Industry Trends
1.3.2 Human Leukocyte Antigen (HLA) Typing Market Drivers & Opportunity
1.3.3 Human Leukocyte Antigen (HLA) Typing Market Challenges
1.3.4 Human Leukocyte Antigen (HLA) Typing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Leukocyte Antigen (HLA) Typing Players Revenue Ranking (2024)
2.2 Global Human Leukocyte Antigen (HLA) Typing Revenue by Company (2020-2025)
2.3 Global Human Leukocyte Antigen (HLA) Typing Players Sales Volume Ranking (2024)
2.4 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Company Players (2020-2025)
2.5 Global Human Leukocyte Antigen (HLA) Typing Average Price by Company (2020-2025)
2.6 Key Manufacturers Human Leukocyte Antigen (HLA) Typing Manufacturing Base and Headquarters
2.7 Key Manufacturers Human Leukocyte Antigen (HLA) Typing Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Human Leukocyte Antigen (HLA) Typing
2.9 Human Leukocyte Antigen (HLA) Typing Market Competitive Analysis
2.9.1 Human Leukocyte Antigen (HLA) Typing Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Human Leukocyte Antigen (HLA) Typing Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Leukocyte Antigen (HLA) Typing as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Reagent
3.1.2 Instrument
3.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Type
3.2.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value, by Type (2020-2031)
3.2.3 Global Human Leukocyte Antigen (HLA) Typing Sales Value, by Type (%) (2020-2031)
3.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Type
3.3.1 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume, by Type (2020-2031)
3.3.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume, by Type (%) (2020-2031)
3.4 Global Human Leukocyte Antigen (HLA) Typing Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Specialty Clinic
4.1.3 Other
4.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Application
4.2.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value, by Application (2020-2031)
4.2.3 Global Human Leukocyte Antigen (HLA) Typing Sales Value, by Application (%) (2020-2031)
4.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Application
4.3.1 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume, by Application (2020-2031)
4.3.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume, by Application (%) (2020-2031)
4.4 Global Human Leukocyte Antigen (HLA) Typing Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region
5.1.1 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region (2020-2025)
5.1.3 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region (2026-2031)
5.1.4 Global Human Leukocyte Antigen (HLA) Typing Sales Value by Region (%), (2020-2031)
5.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region
5.2.1 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region (2020-2025)
5.2.3 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region (2026-2031)
5.2.4 Global Human Leukocyte Antigen (HLA) Typing Sales Volume by Region (%), (2020-2031)
5.3 Global Human Leukocyte Antigen (HLA) Typing Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031
5.4.2 North America Human Leukocyte Antigen (HLA) Typing Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031
5.5.2 Europe Human Leukocyte Antigen (HLA) Typing Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031
5.6.2 Asia Pacific Human Leukocyte Antigen (HLA) Typing Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031
5.7.2 South America Human Leukocyte Antigen (HLA) Typing Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031
5.8.2 Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Leukocyte Antigen (HLA) Typing Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Human Leukocyte Antigen (HLA) Typing Sales Value
6.2.1 Key Countries/Regions Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031
6.2.2 Key Countries/Regions Human Leukocyte Antigen (HLA) Typing Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031
6.3.2 United States Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031
6.4.2 Europe Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031
6.5.2 China Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031
6.5.3 China Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031
6.6.2 Japan Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031
6.7.2 South Korea Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031
6.8.2 Southeast Asia Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Human Leukocyte Antigen (HLA) Typing Sales Value, 2020-2031
6.9.2 India Human Leukocyte Antigen (HLA) Typing Sales Value by Type (%), 2024 VS 2031
6.9.3 India Human Leukocyte Antigen (HLA) Typing Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Information
7.1.2 Thermo Fisher Scientific Introduction and Business Overview
7.1.3 Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Product Offerings
7.1.5 Thermo Fisher Scientific Recent Development
7.2 QIAGEN
7.2.1 QIAGEN Company Information
7.2.2 QIAGEN Introduction and Business Overview
7.2.3 QIAGEN Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 QIAGEN Human Leukocyte Antigen (HLA) Typing Product Offerings
7.2.5 QIAGEN Recent Development
7.3 Illumina
7.3.1 Illumina Company Information
7.3.2 Illumina Introduction and Business Overview
7.3.3 Illumina Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Illumina Human Leukocyte Antigen (HLA) Typing Product Offerings
7.3.5 Illumina Recent Development
7.4 CareDx
7.4.1 CareDx Company Information
7.4.2 CareDx Introduction and Business Overview
7.4.3 CareDx Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 CareDx Human Leukocyte Antigen (HLA) Typing Product Offerings
7.4.5 CareDx Recent Development
7.5 Immucor
7.5.1 Immucor Company Information
7.5.2 Immucor Introduction and Business Overview
7.5.3 Immucor Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Immucor Human Leukocyte Antigen (HLA) Typing Product Offerings
7.5.5 Immucor Recent Development
7.6 Bio-Rad Laboratories, Inc
7.6.1 Bio-Rad Laboratories, Inc Company Information
7.6.2 Bio-Rad Laboratories, Inc Introduction and Business Overview
7.6.3 Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Product Offerings
7.6.5 Bio-Rad Laboratories, Inc Recent Development
7.7 F. Hoffman-La Roche Ltd
7.7.1 F. Hoffman-La Roche Ltd Company Information
7.7.2 F. Hoffman-La Roche Ltd Introduction and Business Overview
7.7.3 F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Product Offerings
7.7.5 F. Hoffman-La Roche Ltd Recent Development
7.8 Hologic, Inc
7.8.1 Hologic, Inc Company Information
7.8.2 Hologic, Inc Introduction and Business Overview
7.8.3 Hologic, Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Hologic, Inc Human Leukocyte Antigen (HLA) Typing Product Offerings
7.8.5 Hologic, Inc Recent Development
7.9 Luminex Corporation
7.9.1 Luminex Corporation Company Information
7.9.2 Luminex Corporation Introduction and Business Overview
7.9.3 Luminex Corporation Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Luminex Corporation Human Leukocyte Antigen (HLA) Typing Product Offerings
7.9.5 Luminex Corporation Recent Development
7.10 Biofortuna
7.10.1 Biofortuna Company Information
7.10.2 Biofortuna Introduction and Business Overview
7.10.3 Biofortuna Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Biofortuna Human Leukocyte Antigen (HLA) Typing Product Offerings
7.10.5 Biofortuna Recent Development
7.11 Bruker
7.11.1 Bruker Company Information
7.11.2 Bruker Introduction and Business Overview
7.11.3 Bruker Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Bruker Human Leukocyte Antigen (HLA) Typing Product Offerings
7.11.5 Bruker Recent Development
7.12 Abbott
7.12.1 Abbott Company Information
7.12.2 Abbott Introduction and Business Overview
7.12.3 Abbott Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Abbott Human Leukocyte Antigen (HLA) Typing Product Offerings
7.12.5 Abbott Recent Development
7.13 Takara Bio Inc
7.13.1 Takara Bio Inc Company Information
7.13.2 Takara Bio Inc Introduction and Business Overview
7.13.3 Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Product Offerings
7.13.5 Takara Bio Inc Recent Development
7.14 Omixon Inc
7.14.1 Omixon Inc Company Information
7.14.2 Omixon Inc Introduction and Business Overview
7.14.3 Omixon Inc Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Omixon Inc Human Leukocyte Antigen (HLA) Typing Product Offerings
7.14.5 Omixon Inc Recent Development
7.15 Siemens
7.15.1 Siemens Company Information
7.15.2 Siemens Introduction and Business Overview
7.15.3 Siemens Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Siemens Human Leukocyte Antigen (HLA) Typing Product Offerings
7.15.5 Siemens Recent Development
7.16 EKF Diagnostics
7.16.1 EKF Diagnostics Company Information
7.16.2 EKF Diagnostics Introduction and Business Overview
7.16.3 EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Product Offerings
7.16.5 EKF Diagnostics Recent Development
7.17 BD
7.17.1 BD Company Information
7.17.2 BD Introduction and Business Overview
7.17.3 BD Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 BD Human Leukocyte Antigen (HLA) Typing Product Offerings
7.17.5 BD Recent Development
7.18 Fujirebio
7.18.1 Fujirebio Company Information
7.18.2 Fujirebio Introduction and Business Overview
7.18.3 Fujirebio Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Fujirebio Human Leukocyte Antigen (HLA) Typing Product Offerings
7.18.5 Fujirebio Recent Development
7.19 TBG Diagnostics Limited
7.19.1 TBG Diagnostics Limited Company Information
7.19.2 TBG Diagnostics Limited Introduction and Business Overview
7.19.3 TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Product Offerings
7.19.5 TBG Diagnostics Limited Recent Development
8 Industry Chain Analysis
8.1 Human Leukocyte Antigen (HLA) Typing Industrial Chain
8.2 Human Leukocyte Antigen (HLA) Typing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Leukocyte Antigen (HLA) Typing Sales Model
8.5.2 Sales Channel
8.5.3 Human Leukocyte Antigen (HLA) Typing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer